GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avadel Pharmaceuticals PLC (FRA:AWK) » Definitions » Cyclically Adjusted Book per Share

Avadel Pharmaceuticals (FRA:AWK) Cyclically Adjusted Book per Share : €1.21 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Avadel Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Avadel Pharmaceuticals's adjusted book value per share for the three months ended in Dec. 2024 was €0.731. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.21 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Avadel Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -4.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Avadel Pharmaceuticals was 6.70% per year. The lowest was -16.70% per year. And the median was -2.90% per year.

As of today (2025-05-10), Avadel Pharmaceuticals's current stock price is €8.30. Avadel Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was €1.21. Avadel Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 6.86.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Avadel Pharmaceuticals was 14.15. The lowest was 0.87. And the median was 6.83.


Avadel Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Avadel Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avadel Pharmaceuticals Cyclically Adjusted Book per Share Chart

Avadel Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 1.06 1.06 1.23 1.21

Avadel Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.20 1.23 1.09 1.21

Competitive Comparison of Avadel Pharmaceuticals's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Avadel Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avadel Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avadel Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Avadel Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Avadel Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Avadel Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.731/122.4391*122.4391
=0.731

Current CPI (Dec. 2024) = 122.4391.

Avadel Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.511 99.975 0.626
201506 0.300 100.573 0.365
201509 0.000 100.274 0.000
201512 1.539 99.676 1.890
201603 1.518 99.676 1.865
201606 1.119 101.072 1.356
201609 0.796 100.274 0.972
201612 0.964 99.676 1.184
201703 1.335 100.374 1.628
201706 1.704 100.673 2.072
201709 2.035 100.474 2.480
201712 1.838 100.075 2.249
201803 1.876 100.573 2.284
201806 1.830 101.072 2.217
201809 1.522 101.371 1.838
201812 0.065 100.773 0.079
201903 -0.227 101.670 -0.273
201906 -0.421 102.168 -0.505
201909 -0.654 102.268 -0.783
201912 -0.700 102.068 -0.840
202003 0.625 102.367 0.748
202006 2.782 101.769 3.347
202009 2.495 101.072 3.022
202012 2.284 101.072 2.767
202103 1.960 102.367 2.344
202106 1.687 103.364 1.998
202109 1.435 104.859 1.676
202112 1.181 106.653 1.356
202203 0.849 109.245 0.952
202206 -0.053 112.779 -0.058
202209 -0.206 113.504 -0.222
202212 -0.318 115.436 -0.337
202303 -0.553 117.609 -0.576
202306 1.479 119.662 1.513
202309 1.154 120.749 1.170
202312 0.895 120.749 0.908
202403 0.750 120.990 0.759
202406 0.679 122.318 0.680
202409 0.698 121.594 0.703
202412 0.731 122.439 0.731

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Avadel Pharmaceuticals  (FRA:AWK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Avadel Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.30/1.21
=6.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Avadel Pharmaceuticals was 14.15. The lowest was 0.87. And the median was 6.83.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Avadel Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Avadel Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Avadel Pharmaceuticals Business Description

Traded in Other Exchanges
Address
10 Earlsfort Terrace, Dublin 2, Dublin, IRL, D02 T380
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.